Lipella Pharmaceuticals Inc. (NASDAQ:LIPO – Get Free Report) shares shot up 31.8% on Tuesday . The stock traded as high as $0.2440 and last traded at $0.2440. 10,536 shares were traded during mid-day trading, an increase of 193% from the average session volume of 3,596 shares. The stock had previously closed at $0.1851.
Lipella Pharmaceuticals Stock Up 31.8%
The firm has a market cap of $1.13 million, a P/E ratio of -0.06 and a beta of 0.07. The stock’s 50-day moving average is $0.22 and its 200-day moving average is $0.43.
About Lipella Pharmaceuticals
Lipella Pharmaceuticals Inc, a biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. The company develops LP-10, a formulation of tacrolimus that has completed Phase 2a clinical trial for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; and LP-410, an oral liposomal formulation of tacrolimus for the treatment of oral graft-versus-host disease (GVHD).
Featured Stories
- Five stocks we like better than Lipella Pharmaceuticals
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Lipella Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lipella Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
